Moderna, Inc. (MUN:0QF)
Germany
· Delayed Price · Currency is EUR | Market Cap | 8.54B |
| Revenue (ttm) | 1.90B |
| Net Income (ttm) | -2.66B |
| Shares Out | n/a |
| EPS (ttm) | -6.86 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 290 |
| Average Volume | 171 |
| Open | 21.70 |
| Previous Close | n/a |
| Day's Range | 21.70 - 23.25 |
| 52-Week Range | 20.18 - 46.34 |
| Beta | n/a |
| RSI | 53.01 |
| Earnings Date | Feb 20, 2026 |
About Moderna
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su... [Read more]
Financial Performance
In 2024, Moderna's revenue was $3.24 billion, a decrease of -52.75% compared to the previous year's $6.85 billion. Losses were -$3.56 billion, -24.46% less than in 2023.
Financial numbers in USD Financial StatementsNews
MRNA Makes Bullish Cross Above Critical Moving Average
In trading on Friday, shares of Moderna Inc (Symbol: MRNA) crossed above their 200 day moving average of $27.68, changing hands as high as $27.75 per share. Moderna Inc shares are currently trading up...
Moderna Inc at Piper Sandler Healthcare Conference Transcript
Moderna Inc at Piper Sandler Healthcare Conference Transcript
Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Moderna, Inc. (MRNA) Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:00 AM ESTCompany ParticipantsJames Mock - Chief Financial...
Moderna (MRNA) Responds to FDA Claims Regarding Vaccine Safety
Moderna (MRNA) Responds to FDA Claims Regarding Vaccine Safety
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2246579336-91445198b50e4bbfa5cea494fbe26b2b.jpg)
S&P 500 Gains and Losses Today: Moderna Plunges; Synopsys Surges on Nvidia Deal
Worries about regulatory headwinds weighed on vaccine producers on Monday, Dec. 1, 2025, while a chip design software maker got a boost from a partnership with an AI darling.
FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks
A report that vaccine approvals could be set to get stricter is pressuring shares of major vaccine makers.
What's Going On With Moderna Stock Monday?
Shares of Moderna, Inc. (NASDAQ: MRNA), along with other vaccine stocks, are trading lower Monday following reports indicating Center for Biologics Evaluation and Research Center Director Vinay Prasa...
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
Memo also reportedly mentions vaccines for flu and pneumonia.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2235242713-88e260dd074d497087b2a80498fe581f.jpg)
Top Stock Movers Now: Coinbase, Robinhood, Moderna, Synopsys, and More
Moderna (MRNA) Shares Drop Amid Stricter FDA Vaccine Approval Standards
Moderna (MRNA) Shares Drop Amid Stricter FDA Vaccine Approval Standards
Moderna, vaccine makers decline following FDA official comments on future approvals
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths
Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.
Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals
The FDA's top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
Stocks making the biggest moves premarket: Synopsys, Moderna, Micron Technology, Wynn Resorts, Coinbase and more
These are some of the stocks posting the largest moves in premarket trading.
Moderna (MRNA) Leads Healthcare Gains with 16.19% Surge
Moderna (MRNA) Leads Healthcare Gains with 16.19% Surge
FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules
The Food and Drug Administration’s top vaccine regulator is pushing new limits on how vaccines win approval. The tougher standards could cloud prospects for vaccine makers and rattle investors in majo...
Noteworthy Friday Option Activity: ULTA, QCOM, MRNA
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Ulta Beauty Inc (Symbol: ULTA), where a total volume of 2,636 contracts has been traded...
Moderna, Inc. (MRNA) Analyst/Investor Day Transcript
Moderna, Inc. ( MRNA) Analyst/Investor Day November 20, 2025 9:00 AM EST Company Participants Stéphane Bancel - CEO & Director Stephen Hoge - President Jerh Collins - Chief Technical Operations & Qua...
Moderna (MRNA) Secures $1.5 Billion Credit Facility to Bolster Clinical Pipeline
Moderna (MRNA) Secures $1.5 Billion Credit Facility to Bolster Clinical Pipeline
Moderna, Inc. (MRNA) Analyst/Investor Day - Slideshow
2025-11-22. The following slide deck was published by Moderna, Inc.
Piper Sandler Lowers Moderna (MRNA) Price Target to $63 | MRNA Stock News
Piper Sandler Lowers Moderna (MRNA) Price Target to $63 | MRNA Stock News
First Week of MRNA July 2026 Options Trading
Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading this week, for the July 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...
Moderna (MRNA) Rating Maintained, Price Target Lowered by RBC Capital | MRNA Stock News
Moderna (MRNA) Rating Maintained, Price Target Lowered by RBC Capital | MRNA Stock News
Noteworthy Thursday Option Activity: JNJ, MRNA, ALB
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Johnson & Johnson (Symbol: JNJ), where a total volume of 39,084 contracts has been trad...